4//SEC Filing
Patel Naimish 4
Accession 0000950170-25-081361
CIK 0001674416other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 9:45 PM ET
Size
5.4 KB
Accession
0000950170-25-081361
Insider Transaction Report
Form 4
Patel Naimish
Chief Medical Officer
Transactions
- Award
Restricted Stock Units
2025-05-30+25,000→ 25,000 total→ Common Shares (25,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
- [F2]This restricted stock unit award was granted on May 30, 2025 with respect to 25,000 Common Shares, with 100% of the shares vesting on May 30, 2028.
Documents
Issuer
CRISPR Therapeutics AG
CIK 0001674416
Entity typeother
Related Parties
1- filerCIK 0002021679
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 9:45 PM ET
- Size
- 5.4 KB